Document is current
Any future updates will be listed below
-
Authors
Ma, Yue
Wang, Yafei
Zhang, Yuwei
Bian, Keyi
Zhu, Yueqiang
Liu, Aidi
Li, Haijie
Yin, Lu
Lu, Hong
Ye, Zhaoxiang https://orcid.org/0000-0003-3157-8393
-
Funding
Funding for this research was provided by:
The Chinese National Key Research and Development Project (2021YFC2500400, 2021YFC2500402)
Tianjin Key Medical Discipline (Specialty) Construction Project (TJYXZDXK-009A)
Tianjin Medical University Cancer Institute and Hospital Fund (B2219)
- License Information
-
More Information
Article History
Received: 4 September 2024
Revised: 12 February 2025
Accepted: 8 March 2025
First Online: 16 April 2025
Compliance with ethical standards
:
: The scientific guarantor of this publication is Dr. Zhaoxiang Ye.
: The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
: One of the authors (Yue Ma) has significant statistical expertise.
: Data of this study was collected from two prospective clinical trials, in which informed consent with agreement for further relevant study was obtained from each patient at the time of enrollment.
: Institutional Review Board approval was obtained (bc2016039, bc2019048).
: The study subjects were collected from two prospective clinical trials, aiming to explore the clinical application guide of CBBCT on diagnosis and neoadjuvant therapy evaluation. There have been several publications that share some same subjects with the current study regarding the diagnosis and evaluation of breast cancer as follows. Our study focused on the characterization of breast cancer on CE-CBBCT images. (1) Zhu et al []. (2) Zhao et al []. (3) Wang et al []. (4) Ma et al []. (5) Ma et al [].
:
